These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11229787)

  • 1. An ideal trial to test differential onset of antidepressant effect.
    Leon AC; Blier P; Culpepper L; Gorman JM; Hirschfeld RM; Nierenberg AA; Roose SP; Rosenbaum JF; Stahl SM; Trivedi MH
    J Clin Psychiatry; 2001; 62 Suppl 4():34-6; discussion 37-40. PubMed ID: 11229787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring onset of antidepressant action in clinical trials: an overview of definitions and methodology.
    Leon AC
    J Clin Psychiatry; 2001; 62 Suppl 4():12-6; discussion 37-40. PubMed ID: 11229782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodology to measure onset of action.
    Thase ME
    J Clin Psychiatry; 2001; 62 Suppl 15():18-21. PubMed ID: 11444762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are two antidepressant mechanisms better than one? Issues in clinical trial design and analysis.
    Leon AC
    J Clin Psychiatry; 2004; 65 Suppl 4():31-6. PubMed ID: 15046539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction: early onset of antidepressant action.
    Rosenbaum JF
    J Clin Psychiatry; 2001; 62 Suppl 4():3. PubMed ID: 11229786
    [No Abstract]   [Full Text] [Related]  

  • 6. ECT and onset of action.
    Roose SP; Nobler M
    J Clin Psychiatry; 2001; 62 Suppl 4():24-6; discussion 37-40. PubMed ID: 11229784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are 2-week trials sufficient to indicate efficacy?
    Montgomery SA
    Psychopharmacol Bull; 1995; 31(1):41-4. PubMed ID: 7675988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A; Brodhead AE; Kolts RL; Brown WA
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI; McFall JP
    J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
    Emslie GJ; Ryan ND; Wagner KD
    J Clin Psychiatry; 2005; 66 Suppl 7():14-20. PubMed ID: 16124837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors contributing to failed trials of new agents: can technology prevent some problems?
    Greist JH; Mundt JC; Kobak K
    J Clin Psychiatry; 2002; 63 Suppl 2():8-13. PubMed ID: 15453008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early onset of antidepressant action: impact on primary care.
    Culpepper L
    J Clin Psychiatry; 2001; 62 Suppl 4():4-6; discussion 37-40. PubMed ID: 11229788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model.
    Santen G; Danhof M; Della Pasqua O
    J Psychiatr Res; 2008 Oct; 42(14):1189-97. PubMed ID: 18353370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["How quickly do antidepressants works"?].
    Regen F; Anghelescu I
    MMW Fortschr Med; 2006 May; Spec no. 2():82-6. PubMed ID: 20104720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing strategies for antidepressant clinical trials: a commentary.
    Robinson DS; Khan A
    J Clin Psychopharmacol; 2004 Feb; 24(1):1-3. PubMed ID: 14709939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.